Skip to main content
Premium Trial:

Request an Annual Quote

RheoGene Names Hood, Ashburner to Scientific Advisory Board

NEW YORK, May 30 – RheoGene, a privately held gene expression company based in Charlottesville, Va., announced Wednesday that it had appointed several genomics industry heavyweights to its scientific advisory board.

Michael Ashburner, the joint head of the European Molecular Biology Laboratory and the European Bioinformatics Institute, and Leroy Hood, director of the Institute for Systems Biology, were both named to the board as was Jeffrey Trent, scientific director of the National Human Genome Research Institute.

Aaron Shatkin, director of the Center for Advanced Biotechnology and Medicince, will serve as chairman of the scientific advisory board.

"We are very pleased that these leading scientists have agreed to help guide research and discovery for RheoGene's products and technologies," Mohan Philip, RheoGene's chief scientific officer, said in a statement.

RheoGene has developed RheoSwitch, a gene expression technology that can turn gene expression on and off and allow it to be dialed up and down. The technology can be applied in proteomics, functional genomics, systems biology, and bioinformatics.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.